Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson's disease - A rCBF scintigraphy study

Acta Neurologica Scandinavica

Volumn 116, Issue 6, 2007, Pages 347-354

  Wallin, A ^a   Ekberg, S ^b   Lind, K ^a   Milos, V ^a   Granerus A K ^b   Granerus, G ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Alzheimer's disease; Blood flow; Cognitive impairment; Parkinson's disease; SPECT

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; IDIOPATHIC DISEASE; MALE; PARKINSON DISEASE; PARKINSONISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN MAPPING; CEREBRAL ARTERIES; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; DEMENTIA; DISEASE PROGRESSION; FEMALE; FUNCTIONAL LATERALITY; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 35748959913     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00887.x     Document Type: Article

References (38)

1. Gibb WR. Dementia and Parkinson's disease. Br J Psychiatry 1989 154 : 596 614.
2. Gasser T. Genetics of Parkinson's disease. J Neurol 2001 248 : 833 40.
3. Rajput AH. Frequency and cause of Parkinson's disease. Can J Neurol Sci 1992 19 (1 Suppl 103 7.
4. Aarsland D, Tandberg E, Larsen JP, Cummings JL. Frequency of dementia in Parkinson disease. Arch Neurol 1996 53 : 538 42.
5. Louis ED, Marder K, Cote L et al. Prevalence of a history of shaking in persons 65 years of age and older: diagnostic and functional correlates. Mov Disord 1996 11 : 63 9.
6. Tison F, Dartigues JF, Auriacombe S, Letenneur L, Boller F, Alperovitch A. Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individuals. Neurology 1995 45 : 705 8.
7. Wallin A, Jennesjö C, Granérus AK. Prevalence of dementia and regional brain syndromes in long-standing Parkinson's disease. Parkinsonism Relat Disord 1999 5 : 103 10.
8. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005 65 : 1239 45.
9. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004 127 (Pt 3) : 550 60.
10. Albert ML, Feldman RG, Willis AL. The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974 37 : 121 30.
11. Cummings JL. The dementias of Parkinson's disease: prevalence, characteristics, neurobiology, and comparison with dementia of the Alzheimer type. Eur Neurol 1988 28 (Suppl. 1 15 23.
12. Boller F, Mizutani T, Roessmann U, Gambetti P. Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol 1980 7 : 329 35.
13. Kramer JH, Duffy JM. Aphasia, apraxia, and agnosia in the diagnosis of dementia. Dementia 1996 7 : 23 6.
14. Malapani C, Pillon B, Dubois B, Agid Y. Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunction. Neurology 1994 44 : 319 26.
15. Pillon B, Dubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology 1991 41 : 634 43.
16. Janvin C, Aarsland D, Larsen JP, Hugdahl K. Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord 2003 15 : 126 31.
17. Zgaljardic DJ, Borod JC, Foldi NS, Mattis P. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn Behav Neurol 2003 16 : 193 210.
18. Fall PA, Axelson O, Fredriksson M et al. Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community. J Clin Epidemiol 1996 49 : 637 41.
19. Stacy M, Jankovic J. Differential diagnosis of Parkinson's disease and the parkinsonism plus syndromes. Neurol Clin 1992 10 : 341 59.
20. Fahn S, Eltor RL. Unified Parkinson's Disease Rating Scale. In : Fahn S, Marsden CD, Calne CB, Goldstein M, eds. Recent developments in Parkinson's disease. Florham Park, NJ : Macmillian Helath Care Information, 1987 153 63, 293 304.
21. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967 17 : 427 42.
22. Webster DD. Critical analysis of the disability in Parkinson's disease. Mod Treat 1968 5 : 257 82.
23. Wallin A, Edman A, Blennow K et al. Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia. J Geriatr Psychiatry Neurol 1996 9 : 185 99.
24. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975 12 : 189 98.
25. Bjorksten KS, Ekberg S, Safstrom P, Dige N, Granerus G. A computerized human reference brain for rCBF/SPET technetium-99m exametazime (HMPAO) investigation of elderly. Clin Physiol Funct Imaging 2004 24 : 196 204.
26. Bissessur S, Tissingh G, Wolters EC, Scheltens P. rCBF SPECT in Parkinson's disease patients with mental dysfunction. J Neural Transm Suppl 1997 50 : 25 30.
27. Derejko M, Slawek J, Lass P, Nyka WM. Cerebral blood flow changes in Parkinson's disease associated with dementia. Nucl Med Rev Cent East Eur 2001 4 : 123 7.
28. Wang SJ, Liu RS, Liu HC et al. Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization. Eur J Nucl Med 1993 20 : 339 44.
29. Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci 2001 22 : 45 6.
30. Tachibana H, Kawabata K, Tomino Y, Sugita M, Fukuchi M. Three-dimensional surface display of brain perfusion with 123I-IMP in Parkinson's disease. Neuroradiology 1994 36 : 276 80.
31. Liu RS, Lin KN, Wang SJ et al. Cognition and 99Tcm-HMPAO SPECT in Parkinson's disease. Nucl Med Commun 1992 13 : 744 8.
32. Sawada H, Udaka F, Kameyama M et al. SPECT findings in Parkinson's disease associated with dementia. J Neurol Neurosurg Psychiatry 1992 55 : 960 3.
33. Emre M. What causes mental dysfunction in Parkinson's disease Mov Disord 2003 18 (Suppl. 6 S63 71.
34. Jellinger KA. Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 2004 111 : 1219 35.
35. Varma AR, Talbot PR, Snowden JS, Lloyd JJ, Testa HJ, Neary D. A 99mTc-HMPAO single-photon emission computed tomography study of Lewy body disease. J Neurol 1997 244 : 349 59.
36. Van Laere K, Santens P, Bosman T et al. Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med 2004 45 : 933 42.
37. Abe Y, Kachi T, Kato T et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 2003 74 : 419 22.
38. Catafau AM, Parellada E, Lomena F et al. Baseline, visual deprivation and visual stimulation 99TCm-HMPAO-related changes in visual cortex can be detected with a single-head SPET system. Nucl Med Commun 1996 17 : 480 4.